FDA announces first-round recipients of national priority voucher program
Regulatory NewsJoanne S. Eglovitch
Approval/marketing authorizationBiologics/ biosimilars/ vaccinesBiotechnologyHealth Authority meeting and communication strategyManufacturingPharmaceuticalsPriority review voucherProduct developmentRegulatory Intelligence/PolicySubmission and registrationUnited StatesUS Food and Drug Administration (FDA)